Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Aspergillus colonization in patients with bronchogenic carcinoma.

Ali S, Malik A, Bhargava R, Shahid M, Fatima N.

Asian Cardiovasc Thorac Ann. 2014 May;22(4):460-4. doi: 10.1177/0218492313513597. Epub 2013 Nov 20.

PMID:
24771735
2.
3.

Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.

Prattes J, Flick H, Prüller F, Koidl C, Raggam RB, Palfner M, Eigl S, Buzina W, Zollner-Schwetz I, Thornton CR, Krause R, Hoenigl M.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):922-9. doi: 10.1164/rccm.201407-1275OC.

PMID:
25203869
4.

Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.

Heng SC, Chen SC, Morrissey CO, Thursky K, Manser RL, De Silva HD, Halliday CL, Seymour JF, Nation RL, Kong DC, Slavin MA.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):322-7. doi: 10.1016/j.diagmicrobio.2014.03.020. Epub 2014 Mar 29.

PMID:
24768294
6.

Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples.

Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AV, Meis JF.

Infection. 1997 Mar-Apr;25(2):86-9.

PMID:
9108182
7.

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.

Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, LeMonte AM, Durkin MM, Knox KS, Hage CA, Bentsen C, Singh N, Wingard JR, Wheat LJ.

Clin Vaccine Immunol. 2008 Dec;15(12):1760-3. doi: 10.1128/CVI.00226-08. Epub 2008 Oct 8.

8.
9.

[Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].

Aydoğan S, Kuştimur S, Kalkancı A.

Mikrobiyol Bul. 2010 Jul;44(3):441-52. Turkish.

PMID:
21063994
10.

The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.

Kono Y, Tsushima K, Yamaguchi K, Kurita N, Soeda S, Fujiwara A, Sugiyama S, Togashi Y, Kasagi S, To M, To Y, Setoguchi Y.

Respir Med. 2013 Jul;107(7):1094-100. doi: 10.1016/j.rmed.2013.04.007. Epub 2013 Apr 28.

11.

Usefulness of serial determination of Aspergillus galactomannan in the diagnosis and management of invasive aspergillosis in an AIDS patient with non-Hodgkin lymphoma.

Antinori S, Ridolfo AL, Galimberti L, Milazzo L, Giuliani G, Ferraris L, Maruzzi M, Corbellino M.

Mycoses. 2011 Nov;54(6):e885-8. doi: 10.1111/j.1439-0507.2011.02034.x. Epub 2011 Jun 14. No abstract available.

PMID:
21672046
12.

Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.

Luong ML, Filion C, Labbé AC, Roy J, Pépin J, Cadrin-Tourigny J, Carignan S, Sheppard DC, Laverdière M.

Diagn Microbiol Infect Dis. 2010 Oct;68(2):132-9. doi: 10.1016/j.diagmicrobio.2010.03.017.

PMID:
20846585
13.

A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia.

Guervilly C, Roch A, Ranque S, Forel JM, Hraiech S, Xeridat F, Adda M, Papazian L.

J Infect. 2012 Nov;65(5):470-3. doi: 10.1016/j.jinf.2012.07.007. Epub 2012 Aug 3. No abstract available.

PMID:
22863901
14.

Prevalence of aspergillosis in bronchogenic carcinoma.

Malik A, Shahid M, Bhargava R.

Indian J Pathol Microbiol. 2003 Jul;46(3):507-10.

PMID:
15025326
15.

Utility of Aspergillus antigen detection in specimens other than serum specimens.

Klont RR, Mennink-Kersten MA, Verweij PE.

Clin Infect Dis. 2004 Nov 15;39(10):1467-74. Epub 2004 Oct 26. Review.

PMID:
15546083
16.

Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.

Miceli MH, Goggins MI, Chander P, Sekaran AK, Kizy AE, Samuel L, Jiang H, Thornton CR, Ramesh M, Alangaden G.

Mycoses. 2015 Jun;58(6):368-74. doi: 10.1111/myc.12327.

17.

Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

Park SY, Lee SO, Choi SH, Sung H, Kim MN, Choi CM, Hong SB, Oh YM, Shim TS, Koh Y, Kim YS, Woo JH, Kim SH.

J Infect. 2010 Dec;61(6):492-8. doi: 10.1016/j.jinf.2010.08.014. Epub 2010 Sep 15.

PMID:
20833201
18.

Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.

Brownback KR, Pitts LR, Simpson SQ.

Mycoses. 2013 Sep;56(5):552-8. doi: 10.1111/myc.12074. Epub 2013 Mar 18.

PMID:
23496321
19.

Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.

Danpornprasert P, Foongladda S, Tscheikuna J.

J Med Assoc Thai. 2010 Jan;93 Suppl 1:S86-93.

PMID:
20364562
20.

Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.

Borrás R, Roselló P, Chilet M, Bravo D, de Lomas JG, Navarro D.

J Clin Microbiol. 2010 Aug;48(8):3035-6. doi: 10.1128/JCM.00902-10. Epub 2010 Jun 16. No abstract available.

Supplemental Content

Support Center